Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Foghorn Therapeutics (FHTX) Return on Assets: 2020-2025

Historic Return on Assets for Foghorn Therapeutics (FHTX) over the last 5 years, with Sep 2025 value amounting to -0.35%.

  • Foghorn Therapeutics' Return on Assets fell 6.00% to -0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.35%, marking a year-over-year decrease of 6.00%. This contributed to the annual value of -0.30% for FY2024, which is 2.00% down from last year.
  • According to the latest figures from Q3 2025, Foghorn Therapeutics' Return on Assets is -0.35%, which was down 8.62% from -0.32% recorded in Q2 2025.
  • Over the past 5 years, Foghorn Therapeutics' Return on Assets peaked at -0.21% during Q1 2022, and registered a low of -0.48% during Q3 2021.
  • Its 3-year average for Return on Assets is -0.31%, with a median of -0.32% in 2023.
  • In the last 5 years, Foghorn Therapeutics' Return on Assets rose by 24bps in 2022 and then declined by 9bps in 2023.
  • Quarterly analysis of 5 years shows Foghorn Therapeutics' Return on Assets stood at -0.29% in 2021, then grew by 3bps to -0.26% in 2022, then fell by 7bps to -0.33% in 2023, then increased by 4bps to -0.29% in 2024, then dropped by 6bps to -0.35% in 2025.
  • Its Return on Assets was -0.35% in Q3 2025, compared to -0.32% in Q2 2025 and -0.30% in Q1 2025.